Dengue virus compartmentalization during antibody-enhanced infection

Eugenia Z Ong1,2, Summer L Zhang2, Hwee Cheng Tan2

  • 1Experimental Therapeutics Centre, Agency for Science, Technology and Research (A*STAR), 138669, Singapore.

Scientific Reports
|January 14, 2017
PubMed
Summary

Secondary dengue virus (DENV) infection risks severe disease via antibody-dependent enhancement (ADE). Leucocyte immunoglobulin-like receptor-B1 (LILRB1) signaling slows DENV